The pathogenesis of inflammatory dermatoses, especially psoriasis;Pathogenese van inflammatoire dermatosen, in het bijzonder psoriasis

Nederlands Tijdschrift voor Geneeskunde

Volumn 150, Issue 4, 2006, Pages 179-183

  Bos, W E M ^a   Thio, H B ^a   Neumann, H A M ^a   Van Der Fits, L ^a   Prens, E P ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE;

ANTIGEN PRESENTING CELL; CELL INTERACTION; CROHN DISEASE; ENVIRONMENTAL FACTOR; HEREDITY; HUMAN; IMMUNITY; IMMUNOREGULATION; KERATINOCYTE; PATHOGENESIS; PHENOTYPE; PSORIASIS; REVIEW; RHEUMATOID ARTHRITIS; SKIN INFLAMMATION; T LYMPHOCYTE;

AUTOANTIBODIES; CYTOKINES; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; PSORIASIS;

EID: 32144455762     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (10)

1. Robert C, Kupper TS. Inflammatory skin diseases, T cells, and immune surveillance. N Engl J Med. 1999;341:1817-28.
2. Allen MH, Ameen H, Veal C, Evans I, Ramrakha-Jones VS, Marsland AM, et al. The major psoriasis susceptibility locus PSORS1 is not a risk factor for late-onset psoriasis. J Invest Dermatol. 2005;124:103-6.
3. Mossner R, Kingo K, Kleensang A, Kruger U, Konig IR, Silm H, et al. Association of TNF-238 and -308 promoter polymorphisms with psoriasis vulgaris and psoriatic arthritis but not with pustulosis palmoplantaris. J Invest Dermatol. 2005;124:282-4.
4. International Psoriasis Genetics Consortium. The International Psoriasis Genetics Study: assessing linkage to 14 candidate susceptibility loci in a cohort of 942 affected sib pairs. Am J Hum Genet. 2003;73:430-7.
5. Naldi L, Chatenoud L, Linder D, Belloni Fortina A, Peserico A, Virgili AR, et al. Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study. J Invest Dermatol. 2005;125:61-7.
6. Lew W, Bowcock AM, Krueger JG. Psoriasis vulgaris: cutaneous lymphoid tissue supports T-cell activation and 'type 1' inflammatory gene expression. Trends Immunol. 2004;25:295-305.
7. Nickoloff BJ, Wrone-Smith T. Injection of pre-psoriatic skin with CD4+ T cells induces psoriasis. Am J Pathol. 1999;155:145-58.
8. Kormeili T, Lowe NJ, Yamauchi PS. Psoriasis: immunopathogenesis and evolving immunomodulators and systemic therapies; U.S. experiences. Br J Dermatol. 2004;151:3-15.
9. Nickoloff BJ, Nestle FO. Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities. J Clin Invest. 2004;113:1664-75.
10. Austin LM, Ozawa M, Kikuchi T, Walters IB, Krueger JG. The majority of epidermal T cells in psoriasis vulgaris lesions can produce type 1 cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alpha, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: a type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients. J Invest Dermatol. 1999;113:752-9.